Page last updated: 2024-08-24

atorvastatin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

atorvastatin has been researched along with 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kinsella, BT; O'Meara, SJ	1
Bianchi, C; Boodhwani, M; Feng, J; Laham, R; Li, J; Mieno, S; Nakai, Y; Ramlawi, B; Sellke, FW; Voisine, P	1

Other Studies

2 other study(ies) available for atorvastatin and 15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid

Article	Year
Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo. British journal of pharmacology, 2004, Volume: 143, Issue:2 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclases; Animals; Atorvastatin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Line; Cell Line, Tumor; Cholesterol; Clinical Trials as Topic; Cyclic AMP; Drug Evaluation, Preclinical; Fatty Acids, Unsaturated; Female; Heptanoic Acids; Humans; Hydantoins; Hydrazines; Iloprost; Ireland; Lipids; Male; Mice; Middle Aged; Propanolamines; Protein Prenylation; Pyrroles; Radioligand Assay; Receptor Cross-Talk; Receptors, Epoprostenol; Receptors, Immunologic; Receptors, Prostaglandin; Signal Transduction; Tritium	2004
High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Circulation, 2006, Jul-04, Volume: 114, Issue:1 Suppl Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Angiostatins; Animals; Apoptosis; Apoptosis Inducing Factor; Arterioles; Atorvastatin; Caspase 3; Caspases; Cholesterol; Coronary Circulation; Coronary Vessels; Drug Evaluation, Preclinical; Endostatins; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Matrix Metalloproteinase 9; Myocardial Ischemia; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptor, TIE-2; Swine; Swine, Miniature; Vascular Endothelial Growth Factor A; Vasodilation	2006

Article

Year

Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo.

British journal of pharmacology, 2004, Volume: 143, Issue:2

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenylyl Cyclases; Animals; Atorvastatin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cell Line; Cell Line, Tumor; Cholesterol; Clinical Trials as Topic; Cyclic AMP; Drug Evaluation, Preclinical; Fatty Acids, Unsaturated; Female; Heptanoic Acids; Humans; Hydantoins; Hydrazines; Iloprost; Ireland; Lipids; Male; Mice; Middle Aged; Propanolamines; Protein Prenylation; Pyrroles; Radioligand Assay; Receptor Cross-Talk; Receptors, Epoprostenol; Receptors, Immunologic; Receptors, Prostaglandin; Signal Transduction; Tritium

2004

High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.

Circulation, 2006, Jul-04, Volume: 114, Issue:1 Suppl

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Angiostatins; Animals; Apoptosis; Apoptosis Inducing Factor; Arterioles; Atorvastatin; Caspase 3; Caspases; Cholesterol; Coronary Circulation; Coronary Vessels; Drug Evaluation, Preclinical; Endostatins; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Gene Expression Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Matrix Metalloproteinase 9; Myocardial Ischemia; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Nitroprusside; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptor, TIE-2; Swine; Swine, Miniature; Vascular Endothelial Growth Factor A; Vasodilation

2006